Meningioma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Sergekorjian (talk | contribs) |
||
Line 6: | Line 6: | ||
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection.<ref name="pmid2399811">{{cite journal| author=Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB| title=Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. | journal=Acta Neuropathol | year= 1990 | volume= 80 | issue= 3 | pages= 311-7 | pmid=2399811 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2399811 }} </ref> | Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection.<ref name="pmid2399811">{{cite journal| author=Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB| title=Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. | journal=Acta Neuropathol | year= 1990 | volume= 80 | issue= 3 | pages= 311-7 | pmid=2399811 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2399811 }} </ref> | ||
==Bromodeoxyuridine Labeling Study== | ==Other Diagnostic Studies== | ||
===Bromodeoxyuridine Labeling Study=== | |||
* An elevated bromodeoxyuridine labeling index of meningioma is associated with:<ref name="pmid2399811">{{cite journal| author=Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB| title=Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. | journal=Acta Neuropathol | year= 1990 | volume= 80 | issue= 3 | pages= 311-7 | pmid=2399811 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2399811 }} </ref> | * An elevated bromodeoxyuridine labeling index of meningioma is associated with:<ref name="pmid2399811">{{cite journal| author=Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB| title=Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. | journal=Acta Neuropathol | year= 1990 | volume= 80 | issue= 3 | pages= 311-7 | pmid=2399811 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2399811 }} </ref> | ||
:* Rapid growth rate of the tumor | :* Rapid growth rate of the tumor |
Revision as of 16:09, 1 October 2015
Meningioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Meningioma other diagnostic studies On the Web |
American Roentgen Ray Society Images of Meningioma other diagnostic studies |
Risk calculators and risk factors for Meningioma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection.[1]
Other Diagnostic Studies
Bromodeoxyuridine Labeling Study
- An elevated bromodeoxyuridine labeling index of meningioma is associated with:[1]
- Rapid growth rate of the tumor
- Greater incidence of recurrence following surgical resection of the tumor
References
- ↑ 1.0 1.1 Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB (1990). "Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence". Acta Neuropathol. 80 (3): 311–7. PMID 2399811.